Institute of Physiology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
IBILI, University of Coimbra, Coimbra, Portugal.
Br J Pharmacol. 2017 Oct;174(20):3514-3526. doi: 10.1111/bph.13756. Epub 2017 Apr 7.
Adiponectin, the most abundant peptide secreted by adipocytes, is involved in the regulation of energy metabolism and vascular physiology. Here, we have investigated the effects of exogenous administration of adiponectin on metabolism, vascular reactivity and perivascular adipose tissue (PVAT) of mesenteric arteries in Wistar rats fed a high-fat diet.
The effects of adiponectin on NO-dependent and independent vasorelaxation were investigated in isolated mesenteric arteries from 12-month-old male Wistar rats (W12m) fed a high-fat diet (HFD) for 4 months and compared with those from age-matched rats given a control diet. Adiponectin ((96 μg·day ) was administered by continuous infusion with a minipump, implanted subcutaneously, for 28 days.
Chronic adiponectin treatment reduced body weight, total cholesterol, free fatty acids, fasting glucose and area under the curve of intraperitoneal glucose tolerance test, compared with HFD rats. It also normalized NO-dependent vasorelaxation increasing endothelial NO synthase (eNOS) phosphorylation in mesenteric arteries of HFD rats. In PVAT from aged (W12m) and HFD rats there was increased expression of chemokines and pro-inflammatory adipokines, the latter being important contributors to endothelial dysfunction. Infusion of adiponectin reduced these changes.
Adiponectin normalized endothelial cell function by a mechanism that involved increased eNOS phoshorylation and decreased PVAT inflammation. Detailed characterization of the adiponectin signalling pathway in the vasculature and perivascular fat is likely to provide novel approaches to the management of atherosclerosis and metabolic disease.
This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue - Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc.
脂联素是脂肪细胞分泌的最丰富的肽,参与能量代谢和血管生理学的调节。在这里,我们研究了外源性给予脂联素对高脂饮食喂养的 Wistar 大鼠肠系膜动脉代谢、血管反应性和血管周围脂肪组织(PVAT)的影响。
我们在 12 个月大的雄性 Wistar 大鼠(W12m)中研究了脂联素对 NO 依赖性和非依赖性血管舒张的影响,这些大鼠连续 4 个月喂食高脂肪饮食(HFD),并与喂食对照饮食的同龄大鼠进行比较。脂联素(96μg·天)通过皮下植入的微量泵持续输注 28 天。
与 HFD 大鼠相比,慢性脂联素治疗降低了体重、总胆固醇、游离脂肪酸、空腹血糖和腹腔葡萄糖耐量试验的曲线下面积。它还使 HFD 大鼠肠系膜动脉中 NO 依赖性血管舒张正常化,增加内皮型一氧化氮合酶(eNOS)磷酸化。在年龄较大(W12m)和 HFD 大鼠的 PVAT 中,趋化因子和促炎脂肪因子的表达增加,后者是内皮功能障碍的重要贡献者。脂联素的输注减少了这些变化。
脂联素通过增加 eNOS 磷酸化和减少 PVAT 炎症的机制使内皮细胞功能正常化。对血管和血管周围脂肪中脂联素信号通路的详细特征描述可能为动脉粥样硬化和代谢性疾病的治疗提供新的方法。
本文是一个关于分子机制调节血管周围脂肪组织的专题部分的一部分-潜在的药理学靶点?要查看本部分的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc。